{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:14Z","timestamp":1792521434474,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1097\/01.inf.0000220209.35074.0b","type":"journal-article","created":{"date-parts":[[2006,6,22]],"date-time":"2006-06-22T05:33:10Z","timestamp":1150954390000},"page":"615-622","source":"Crossref","is-referenced-by-count":52,"title":["The Safety and Immunogenicity of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children"],"prefix":"10.1097","volume":"25","author":[{"given":"Jay M.","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Shinefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D.","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Werzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hartzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Klopfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Sch\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210202","first-page":"389","article-title":"Vaccines, 4th ed.","author":"Strebel","year":"2004"},{"key":"R2-10-20210202","first-page":"441","article-title":"Vaccines, 4th ed.","author":"Plotkin","year":"2004"},{"key":"R3-10-20210202","first-page":"707","article-title":"Vaccines, 4th ed.","author":"Plotkin","year":"2004"},{"key":"R4-10-20210202","first-page":"783","article-title":"Vaccines, 4th ed.","author":"Gershon","year":"2004"},{"key":"R5-10-20210202","first-page":"Q1","article-title":"Recommended childhood and adolescent immunization schedule\u2014United States, 2005.","volume":"53","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-10-20210202","first-page":"717","article-title":"National, state, and urban area vaccination levels among children aged 19\u201335 months\u2014United States, 2004.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10-10-20210202","article-title":"Canadian Immunization Guide, 6th ed.","year":"2002"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/infdis\/149.5.810","article-title":"Epidemiological standardization of a test for susceptibility to mumps.","volume":"149","author":"Shehab","year":"1984","journal-title":"J Infect Dis"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0166-0934(86)90048-0","article-title":"Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.","volume":"14","author":"Keller","year":"1986","journal-title":"J Virol Methods"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jmv.1890320310","article-title":"Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen.","volume":"32","author":"Wasmuth","year":"1990","journal-title":"J Med Virol"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0264-410X(91)90266-9","article-title":"Antibody assay suitable for assessing immune responses to live varicella vaccine.","volume":"9","author":"Provost","year":"1991","journal-title":"Vaccine"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00006454-200204000-00014","article-title":"Inverse relationship between 6 week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection.","volume":"21","author":"Li","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States.","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"R17-10-20210202","first-page":"884","article-title":"Decline in annual incidence of varicella\u2014Selected states, 1990\u20132001.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization.","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"key":"R19-10-20210202","first-page":"545","article-title":"Varicella-related deaths\u2014United States, 2002.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/clinids\/24.5.925","article-title":"Measles, mumps, rubella, and varicella combination vaccine: Safety and immunogenicity alone and in combination with other vaccines given to children.","volume":"24","author":"White","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R22-10-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1542\/peds.61.1.5","article-title":"Persistence of antibody after the administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.","volume":"61","author":"Weibel","year":"1978","journal-title":"Pediatrics"},{"key":"R23-10-20210202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or 2 injections of varicella vaccine.","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","article-title":"MMR vaccination and febrile seizures: Evaluation of susceptible subgroups and long-term prognosis.","volume":"292","author":"Vestergaard","year":"2004","journal-title":"JAMA"},{"key":"R25-10-20210202","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF01253813","article-title":"Immunization with live attenuated measles virus vaccine: 5 years experience.","volume":"16","author":"Katz","year":"1965","journal-title":"Arch Geasmte Virus Fasch"},{"key":"R26-10-20210202","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1212\/WNL.60.2.E1","article-title":"Seizures in children with fever: Generally good outcome.","volume":"60","author":"Jankowiak","year":"2003","journal-title":"Neurology"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200607000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T16:14:25Z","timestamp":1683476065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200607000-00010"}},"subtitle":["A Study of Manufacturing Consistency and Persistence of Antibody"],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000220209.35074.0b","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}